project id: TCGA-BRCA; case submitter id: TCGA-B6-A400; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.54; rna integrity number: 9.2; age at index: 43; days to birth: -16022; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1965; age at diagnosis: 16022; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 215.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1610; initial weight: 20.0; sample id: 5012e9c0-a0f3-4f57-8840-fee059dfe671; sample submitter id: TCGA-B6-A400-01A; portion id: 66a5fbad-6d93-4d8e-9d16-9a50aab1ecc8; portion submitter id: TCGA-B6-A400-01A-11; slide id: 825ac7bc-8a50-49c2-8346-8f39a55d117b; slide submitter id: TCGA-B6-A400-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 75.0; section location: TOP;